STOCK TITAN

[Form 4] Natera, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Natera, Inc. (NTRA) insider transaction: A reporting person who serves as Executive Chairman and Director sold 10,000 shares of Natera common stock on 10/20/2025 at a price of $190 per share, coded as an open-market sale (S). The trade was executed under a Rule 10b5-1 trading plan adopted on June 13, 2025.

Following the transaction, the reporting person beneficially owned 2,320,852 shares directly and 5,000 shares indirectly through a spouse.

Natera, Inc. (NTRA) operazione di insider: Una persona reportante che ricopre i ruoli di Executive Chairman e Director ha venduto 10.000 azioni ordinarie di Natera il 20/10/2025 al prezzo di 190 dollari per azione, classificata come vendita sul mercato aperto (S). L'operazione è stata eseguita secondo un piano di trading Rule 10b5-1 adottato il 13 giugno 2025.

A seguito della transazione, la persona che segnala detiene beneficiamente 2.320.852 azioni direttamente e 5.000 azioni indirettamente tramite un coniuge.

Transacción de insider de Natera, Inc. (NTRA): Una persona informante que sirve como Executive Chairman y Director vendió 10,000 acciones de las acciones comunes de Natera el 20/10/2025 a un precio de 190 dólares por acción, codificada como una venta en el mercado abierto (S). La operación se ejecutó bajo un plan de negociación Rule 10b5-1 adoptado el 13 de junio de 2025.

Tras la transacción, la persona informante posee beneficiosamente 2,320,852 acciones directamente y 5,000 acciones indirectamente a través de un cónyuge.

Natera, Inc. (NTRA) 내부자 거래: 보고자는 Executive Chairman 및 이사로 재직하며 2025년 10월 20일 주당 190달러의 가격으로 Natera 보통주 10,000주를 매도했고, 이는 공개시장 매각(S)로 분류되었다. 거래는 2025년 6월 13일에 채택된 Rule 10b5-1 거래 계획 아래에서 실행되었다.

거래 후 보고자는 직접 2,320,852주, 배우자를 통한 간접 5,000주를 보유하게 되었다.

Natera, Inc. (NTRA) opération d'initié : Une personne qui agit comme Executive Chairman et Director a vendu 10 000 actions ordinaires de Natera le 20/10/2025 au prix de 190 dollars par action, codée comme une vente sur le marché libre (S). La transaction a été exécutée dans le cadre d'un plan de trading Rule 10b5-1 adopté le 13 juin 2025.

Suite à la transaction, la personne déclarante détenait directement 2 320 852 actions et 5 000 actions indirectement par le biais d'un conjoint.

Natera, Inc. (NTRA) Insider-Transaktion: Eine meldende Person, die als Executive Chairman und Director fungiert, hat 10.000 Aktien der Natera-Stammaktie am 20.10.2025 zu einem Preis von 190 USD pro Aktie verkauft, kodiert als Open-Market-Verkauf (S). Der Handel wurde im Rahmen eines am 13. Juni 2025 eingeführten Rule 10b5-1-Handelsplans durchgeführt.

Nach der Transaktion hielt die meldende Person direkt 2.320.852 Aktien und indirekt 5.000 Aktien über den Ehepartner.

صفقة داخلية من Natera, Inc. (NTRA): فرد مُبلّغ يُشغل منصب الرئيس التنفيذي ورئيس مجلس الإدارة والمدير باع 10,000 سهم من أسهم Natera العادية في 20/10/2025 بسعر 190 دولارًا للسهم، مصنّف كبيع في السوق المفتوح (S). تمت الصفقة بموجب خطة تداول Rule 10b5-1 التي اعتمدت في 13 يونيو 2025.

بعد الصفقة، امتلك الشخص المبلّغ بشكل فعّال 2,320,852 سهمًا مباشرة و5,000 سهم بشكل غير مباشر عبر زوج/ة.

Natera, Inc. (NTRA) 内部交易: 一名披露人担任执行主席兼董事,自2025年10月20日以每股190美元的价格出售了10,000股Natera普通股,交易被编码为公开市场出售(S)。该交易是在2025年6月13日通过的Rule 10b5-1交易计划下执行的。

交易完成后,该披露人直接持有2,320,852股,及通过配偶间接持有5,000股。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Natera, Inc. (NTRA) operazione di insider: Una persona reportante che ricopre i ruoli di Executive Chairman e Director ha venduto 10.000 azioni ordinarie di Natera il 20/10/2025 al prezzo di 190 dollari per azione, classificata come vendita sul mercato aperto (S). L'operazione è stata eseguita secondo un piano di trading Rule 10b5-1 adottato il 13 giugno 2025.

A seguito della transazione, la persona che segnala detiene beneficiamente 2.320.852 azioni direttamente e 5.000 azioni indirettamente tramite un coniuge.

Transacción de insider de Natera, Inc. (NTRA): Una persona informante que sirve como Executive Chairman y Director vendió 10,000 acciones de las acciones comunes de Natera el 20/10/2025 a un precio de 190 dólares por acción, codificada como una venta en el mercado abierto (S). La operación se ejecutó bajo un plan de negociación Rule 10b5-1 adoptado el 13 de junio de 2025.

Tras la transacción, la persona informante posee beneficiosamente 2,320,852 acciones directamente y 5,000 acciones indirectamente a través de un cónyuge.

Natera, Inc. (NTRA) 내부자 거래: 보고자는 Executive Chairman 및 이사로 재직하며 2025년 10월 20일 주당 190달러의 가격으로 Natera 보통주 10,000주를 매도했고, 이는 공개시장 매각(S)로 분류되었다. 거래는 2025년 6월 13일에 채택된 Rule 10b5-1 거래 계획 아래에서 실행되었다.

거래 후 보고자는 직접 2,320,852주, 배우자를 통한 간접 5,000주를 보유하게 되었다.

Natera, Inc. (NTRA) opération d'initié : Une personne qui agit comme Executive Chairman et Director a vendu 10 000 actions ordinaires de Natera le 20/10/2025 au prix de 190 dollars par action, codée comme une vente sur le marché libre (S). La transaction a été exécutée dans le cadre d'un plan de trading Rule 10b5-1 adopté le 13 juin 2025.

Suite à la transaction, la personne déclarante détenait directement 2 320 852 actions et 5 000 actions indirectement par le biais d'un conjoint.

Natera, Inc. (NTRA) Insider-Transaktion: Eine meldende Person, die als Executive Chairman und Director fungiert, hat 10.000 Aktien der Natera-Stammaktie am 20.10.2025 zu einem Preis von 190 USD pro Aktie verkauft, kodiert als Open-Market-Verkauf (S). Der Handel wurde im Rahmen eines am 13. Juni 2025 eingeführten Rule 10b5-1-Handelsplans durchgeführt.

Nach der Transaktion hielt die meldende Person direkt 2.320.852 Aktien und indirekt 5.000 Aktien über den Ehepartner.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rabinowitz Matthew

(Last) (First) (Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TX 78753

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
EXECUTIVE CHAIRMAN
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 2,320,852 D
Common Stock 10/20/2025 S 10,000(1) D $190 5,000 I By spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 13, 2025.
/s/ Vincent Fontanilla, Attorney-in-Fact 10/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Natera (NTRA) disclose in this Form 4?

An insider sold 10,000 shares of common stock at $190 on 10/20/2025 under a Rule 10b5-1 plan.

Who made the trade and what is their role at Natera (NTRA)?

The reporting person is an Executive Chairman and Director.

How many shares does the insider hold after the sale?

Beneficial ownership after the sale is 2,320,852 shares directly and 5,000 shares indirectly through a spouse.

When was the Rule 10b5-1 plan adopted?

The plan was adopted on June 13, 2025.

What was the transaction code used?

The transaction was coded S, indicating an open-market sale.

Was this filing made by multiple reporting persons?

No. It was filed by one reporting person.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

25.65B
132.34M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN